Background. Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated. Methods. A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events. Results. Baseline characteristics (nϭ280) are as follows: mean age 48.6 years (Ϯ11.5 standard deviation), 66% men, diabetes duration 22.6 years (meanϮ8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98 -17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (Ն70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events. Conclusion. DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.
D
iabetes mellitus patients have a markedly increased risk of cardiovascular (CV) disease compared with nondiabetics and have greater mortality after acute coronary events. Diabetic patients are an increasingly common population to develop end-stage renal disease (ESRD) and when compared with patients with other causes of ESRD, they suffer increased risk of morbidity and mortality (1) (2) (3) .
Renal transplantation is considered the treatment of choice for patients with ESRD. This is because of mortality is significant reduced in transplant recipient compared with those patients who remain on dialysis, which is consistent within the diabetic subpopulation (4, 5) .
Unfortunately, CV disease remains the leading cause of mortality in both dialysis and transplant recipients (6) . Although contemporary consensus guidelines would suggest a selective conservative approach to risk stratification of this population, there is limited evidence specific to this subgroup of patients with diabetes and renal insufficiency (7) (8) (9) . In an attempt to reduce CV events during the perioperative period and after transplantation, cardiac screening for patients with ESRD being considered for renal transplantation has been recommended, and many programs undertake routine invasive CV assessment before clearance for renal transplantation (10) . The competing risks of potentially improving outcomes through documentation of high-risk coronary anatomy compared with the risk of the invasive procedure warrant careful consideration. Despite this information and recommendation, few studies have examined the effectiveness of an invasive risk stratification approach to screening diabetic patients with ESRD being assessed for renal transplantation.
Accordingly, we examined a prospective population of diabetic patients deemed to be candidates for renal transplan-tation within a tertiary care center. Our objectives were to provide descriptive information specific to clinical parameters and of noninvasive and invasive cardiac investigations. The second objective was to correlate patients' clinical characteristics and noninvasive cardiac investigation with incidence of clinically significant coronary artery disease (CAD). The final and key objective was to determine the predictors of major adverse cardiac events to illuminate the most clinically effective means of cardiac risk stratification of diabetic patients with ESRD being assessed for renal transplantation.
RESULTS
Two hundred eighty consecutive patients with diabetes and end-stage renal failure and considered candidates for renal transplantation were enrolled. Baseline demographics, standard CV risk factors, and CV medications are presented in Table 1 . By design, all patients had diabetic nephropathy with one fifth being predialysis at the time of enrollment, that is, initial cardiology assessment. The majority (79%) of patients had at least one other documented diabetic complication. Hematologic and biochemical testing demonstrated suboptimal cholesterol profiles (total cholesterol 5.17Ϯ1.40 mmol/L; low-density lipoprotein 3.05Ϯ1.03), increased homocysteine (22.98Ϯ12.46 mol/L), and increased hemoglobin A1C levels (0.076%Ϯ0.016%).
The 12-lead electrocardiogram (ECG) was interpreted as normal in approximately 30% of patients. Of the ECGs deemed abnormal, 19.5% had diagnostic Q-waves. At the time of noninvasive imaging, the majority of patients underwent pharmacologic graded stress with dipyridamole, consistent with the high degree of diabetic neuropathy and generalized deconditioning of the study population. Of the small group (nϭ21) that underwent exercise stress testing before myocardial perfusion imaging, two were interpreted as electrocardiographically positive for myocardial ischemia. Noninvasive CV investigations completed included myocardial perfusion imaging in 245 patients with reversible perfusion defects (myocardial ischemia) in 13.9%, fixed perfusion defects (myocardial infarction) in 6.5%, or both reversible and fixed perfusion defects in 7.3%; 27.8% had at least one perfusion abnormality demonstrated. Analysis of left ventricular function was available in 118 patients who underwent myocardial perfusion imaging: left ventricular function more than or equal to 60% in 34.7%, more than or equal to 40% to 59% in 57.6%, and less than 40 in 7.6%.
Coronary angiography completed in 234 patients identified CAD in the majority with 56.5% having at least one coronary stenosis in a major coronary artery more than or equal to 50%. Univariate predictors of CAD (Ն50%, Ն70%, and ՆDuke angiographic 4) are shown in Figure 1 . In multivariable analysis, positive myocardial perfusion imaging (defined as fixed or reversible defects) was the only predictor of CAD (Ն70%; odds ratio [OR] 7.18, 95% confidence interval [CI] 2.98 -17.3, PϽ0.0001) with age (OR 1.73, 95% CI 0.95-3.14, Pϭ0.007) and male gender (OR 1.72, 95% CI 0.90 -3.30, Pϭ0.10) demonstrating trends. Although a positive myocardial perfusion study was strongly predictive of the presence of CAD more than or equal to 70% (specificity 95/102ϭ93.1% and positive predictive value 50/57ϭ87.7%), a poor negative predicted value (95/147ϭ64.6%) was observed. Specifically, a negative myocardial perfusion scan occurred in 50.3%, 35.4%, and 41.8% of patients with a coronary artery stenosis more than or equal to 50%, more than or equal to 70%, or with a Duke angiographic score more than or equal to 4 (predictive of severe CAD), respectively ( Table 2 ). Regarding the myocardial perfusion imaging (reversible or fixed defect) ability to predict more than or equal to 70% coronary artery stenosis, a sensitivity of 49.0% was demonstrated. Of those with falsenegative myocardial perfusion results (52/102ϭ51.0%), 38% had single-vessel, 38% had two-vessel, and 24% had three-vessel CAD.
After a mean follow-up of 4 years (median 3.9 years), 82 of 280 (29%) patients had suffered a major adverse cardiac event. The majority of documented clinical events were related to mortality with total events, and causes of death are shown in Table 3 . Univariate predictors of major adverse cardiovascular events are shown in Figure 2 . In multivariable Cox regression analysis, angiographic evidence of CAD (Ն70% hazard ratio 1.81 [1.016 -3.23], Pϭ0.044) was the only predictor of major adverse cardiac events. During the period of follow-up, 133 patients had renal transplantation that occurred 2.9 years (mean; 2.2 years median) after enrollment, that is, from time of initial cardiology assessment. Major adverse cardiac events occurred perioperatively in 11 of 133 (8.3%) patients with renal transplantation. Of those patients who died after renal transplantation, death occurred perioperatively in two, within 6 months in two, between 6 months and 1 year in two, from 1 to 2 years in three, and after 2 years in seven. Univariate and multivariable analyses identified no significant predictors of mortality.
Coronary revascularization was undertaken in 41 patients with 24 having percutaneous coronary intervention and 17 undergoing coronary artery bypass grafting: all occurring before renal transplantation. The group undergoing revascularization was more likely to have a past history of CAD (56.1% vs. 18.5%, PϽ0.0001), positive myocardial perfusion imaging (59.5% vs. 13.2%, PϽ0.0001), and increased frequency (Ն70% CAD 97.6% vs. 37%) and severity of CAD (Duke angiographic score Ն4 80.5% and 13.2%, PϽ0.0001) at the time of diagnostic angiography.
DISCUSSION
This consecutive cohort of patients with chronic renal insufficiency and diabetes being assessed for renal transplantation demonstrates frequent CV risk factors, a high likelihood of significant coronary artery stenosis, and a 29% incidence of major adverse cardiac events after 4 years of follow-up including an 8.3% renal transplant perioperative event rate. Although myocardial perfusion imaging was the only independent predictor of angiographically significant CAD and may guide revascularization decisions, this noninvasive assessment was of limited clinical utility as a screening tool for CAD in this patient population with a high false-negative rate. Furthermore, angiographic evidence of CAD was the only independent predictor of major adverse cardiac events.
In terms of risk factors, it is well established that diabetic patients with ESRD have multiple CV risk factors and diminished functional capacity, a generalization that is consistent with our results despite the populations relatively young age (median 48 years). Despite the large number of patients with angiographic coronary stenosis that would typically be associated with angina symptoms, few patients reported symptomatic limitations. This is consistent with the known risk of asymptomatic ischemia and myocardial infarction in this population in part due to diabetic neuropathy (11, 12) . It may also be related to the cohorts generalized inactivity where the metabolic activity required to invoke myocardial ischemia is infrequent. Furthermore, the constitutional symptom associated with chronic renal insufficiency may lead to misinterpretation of symptoms. These factors add a further dimension of complexity to the clinical assessment of this patient population before renal transplantation.
From a CV point of view, the medical therapy in this population seems suboptimal. Although roughly half (47%) were diagnosed with hypercholesterolemia, only 28% were being treated with cholesterol-lowering medication at the time of initial cardiology consult. The largest study looking at CV endpoints in diabetic patients was the Heart Protection Study (13) . This study involved 5693 diabetic patients and demonstrated that simvastatin sufficiently lowered the risk of major vascular events. A high percentage (92.2%) of patients in our study had hypertension, with one third of patients showing signs of left ventricular hypertrophy on ECG. With FIGURE 1. Univariate predictors of angiographic coronary artery disease (CAD; nϭ234). "Univariate predictors of angiographic coronary artery disease more than or equal to 50% (A), more than or equal to 70 (B), and more than or equal to 4 Duke angiographic score (C) …" including clinical characteristics and noninvasive investigations are shown as odds ratio with 95% confidence intervals. Pos Fam Hx, premature family history of coronary artery disease; Htn, hypertension; Hypercholest, hypercholesterolemia; Diab, more than 22 years, median duration of diabetes; PVD, peripheral vascular disease; ECG, electrocardiogram; MIBI, perfusion defect (fixed or reversible). such a high percentage of patients having hypertension, it was also a little surprising that only 40% of patients were taking an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. This apparent "under treatment" must take into context the complexity of medically managing this patient population and the contradictory results of research for secondary prevention in patients with ESRD.
Rabbat et al. (14) published a meta-analysis of 12 myocardial perfusion imaging studies in patients with ESRD being assessed for renal transplant. Seven of the 12 studies included patients with diabetes with a total of 338 diabetic patients assessed. A positive noninvasive test was associated with increased risk of both cardiac death and myocardial infarction. Therefore, it was suggested that a negative noninvasive result could be used to rule out high-risk patients, whereas positive noninvasive result requires further evaluation through coronary angiography. Our current results concur with the conclusion that positive myocardial perfusion imaging is associated with increased risk and warrants further investigation. Unlike prior analyses, all patients in our study were scheduled to receive both noninvasive and invasive testing. Thus, patients with negative noninvasive testing were still sent for coronary angiograms, and an alarming numbers were found to have angiographically significant CAD. Many patients (35.4%) with negative myocardial perfusion imaging did in fact have coronary stenosis greater than 70% in a major epicardial artery: with nearly an equal distribution of one-, two-, and three-vessel CAD. Therefore, in contrast to Rabbat et al.'s conclusion, our results found little utility of myocardial perfusion imaging as a screening tool, that is, in predicting the presence of significant angiographic CAD with a high false-negative rate. Furthermore, in our study, angiographic evidence of CAD was the only predictor of subsequent major adverse cardiac events. This interpretation of our results is supported by work from De Lima et al. (15) who found that coronary lesion documented by angiography were the sole predictor of cardiac events in moderate to high risk patients (including diabetics) being assessed for renal transplantation.
The high false-negative rate limits the utility of myocardial perfusion imaging in this population as a screening tool for the detection of angiographic significant coronary artery stenosis. Although "balance ischemia" may contribute to a small portion of these false-negative tests, it seems unlikely to explain the majority because the patients were nearly equally balanced between single-, double-, and triple-vessel disease. It is possible that the combination of chronic renal insufficiency and diabetes with associated impaired endothelial function limits the ability of dipyridamole to achieve adequate coronary vasodilatation in this patient population, thereby limiting the efficacy of pharmacologic stress. This concept and potential limitation of the noninvasive assessment require further consideration and formal investigation.
Current evidence and guidelines recommend a selective strategy of CV risk assessment in patients undergoing nonvascular surgery. The American College of Cardiology and American Heart Association guideline update on perioperative CV evaluation for noncardiac surgery defines a stepwise approach to preoperative risk assessment, which incorporates the type and urgency of the surgical procedure, clinical predictors, and patients' functional capacity (9) . The specific population under discussion in this article would be considered of intermediate clinical risk; therefore, if their functional capacity was more than or equal to 4 metabolic equivalents (i.e., able to climb a flight of stairs), they would proceed to surgery without noninvasive or invasive cardiac investigation. In those patients with diminished functional capacity, noninvasive cardiac investigation is encouraged with subsequent coronary angiography in the setting of highrisk results. In contrast to these recommendations, many transplant centers undertake routine noninvasive and liberal invasive cardiac investigation in diabetic patients being assessed for renal transplantation. The current analysis demonstrates that guideline defined investigation would fail to identify significant CAD in a substantial number of patients (4.4) in this specific population, although it must be acknowledged that evidence to support the clinical impact of this is currently lacking. Although there were no documented adverse events after cardiac catheterization in our study, the possibility of adverse events after cardiac catheterization and timing of invasive assessment must balance the competing risks of documenting high-risk coronary anatomy compared with the risk of the invasive procedure because acute renal insufficiency postcardiac catheterization has been associated with increased morbidity (16) . In the past, clinical risk scores have been developed in an attempt to selectively investigate patients with renal insufficiency before renal transplantation. Gupta et al. (17) assessed clinical factors associated with mortality after renal transplant. Their analysis highlights the reality that the specific population addressed in the current analysis is consistently in the moderately high to high-risk group and experiences the poorest outcomes. To date, there is no proposed risk score specific to the diabetic population.
Limitations
This observational study is associated with limitations regarding the possibility of assigning cause and effect relationships. We attempted to diminish the risk of selection bias by undertaking a prospective consecutive cohort design, although data were collected retrospectively. To maximize consistency, data collection was completed by trained experienced data analysts working within a research organization with experience in this area. This study does not address the potential impact of other forms of noninvasive functional cardiac imaging including stress echocardiography or cardiac magnetic resonance imaging. Conclusions regarding outcomes in this population and the impact of our screening program are not possible: specifically, although coronary stenosis predicted adverse cardiac events, does revascularization in response to this knowledge affect clinical outcome? (18, 19) .
CONCLUSION
This study represents the largest single study specifically addressing diabetic patients with ESRD undergoing assessment for renal transplantation. Most remarkably, the results show a large number of diabetic patients with no apparent CV symptoms having significant CAD as diagnosed by cardiac catheterization, which was the only independent predictor of major adverse cardiac events. Further research is needed to address risk modeling useful in the cardiac assessment of this population before renal transplantation. Furthermore, the impact of the knowledge of coronary anatomy and revascularization on long-term event free survival requires further investigation.
MATERIALS AND METHODS
Patients with diabetes and ESRD deemed potentially eligible for renal transplantation according to a nephrologists-based renal transplantation team were seen by cardiologists with specific interest in risk assessment in this population. They were followed up prospectively from the time of the original cardiology clinical assessment until study follow-up was closed over a 12-year period (May 1991 to June 2003, data base lock July 1, 2003) .
Clinical assessment included a thorough medical history and documentation of hematologic and biochemical parameters completed through detailed chart abstraction undertaken by an experienced data analyst working with the Epidemiology Coordinating and Research Centre at the University of Alberta. Noninvasive assessment included baseline ECG and nuclear myocardial perfusion imaging through exercise or pharmacologic stress. All patients were referred for cardiac catheterization and coronary angiography. After initial assessment, patients were routinely screened with clinical assessment and repeat myocardial perfusion imaging (typically once yearly) at a frequency dependent on coronary anatomy and the patients overall risk profile.
The primary endpoint was the ability of clinical parameters and noninvasive imaging to detect angiographic CAD defined by experienced cardiologists using visual estimates at more than or equal to 50% and more than or equal to 70%, and a Duke angiographic score was calculated with a score of more than or equal to 4 considered high risk. The Duke angiographic score defines the degree and location of coronary artery stenosis and has been correlated to adverse cardiac events and previously validated (20) . Only patients who had undergone both noninvasive imaging and coronary angiography were included in this analysis. Secondary endpoints included all-cause mortality, myocardial infarction, unstable angina, cerebral vascular accident, significant arrhythmia, and revascularization (percutaneous coronary intervention or coronary artery bypass grafting). The primary clinical outcome was a composite of major adverse clinical events including mortality, myocardial infarction, unstable angina, significant arrhythmia, and cerebral vascular accident.
Multivariable analysis was completed to assess factors predictive of angiographic CAD and the composite outcomes (major adverse cardiac events). A range of demographic, clinical, and noninvasive procedures were selected as independent predictors. These predictors were independently tested in a univariate logistic regression model and those that achieved a significance level of P less than 0.2 were adjusted for in the multivariable models. Variables significant at the 0.05 level and important strata variables including age and FIGURE 2. Univariate predictors of major adverse cardiac events (nϭ234). Univariate predictors of major adverse cardiac events including clinical characteristics, noninvasive and invasive investigations. Hypercholest, hypercholesterolemia, more than or equal to 70% CAD, more than or equal to 70% coronary artery disease in a major epicardial vessel; more than or equal to 50% CAD, more than or equal to 50% coronary artery disease in a major epicardial vessel; Positive ECHO, positive stress echocardiography; duration more than 22 years, median duration of diabetes.
sex were used in the final model. For simplification of interpretation, continuous variables were dichotomized by splitting at the median level. Survival analysis was performed from the date of initial cardiology consultation until data base closure (July 1, 2003) , which looked at the entire event free survival experience of the cohort. Other analyses looked at what factors were associated with the individual components of major adverse cardiac events and the combined endpoint. The adjusted and unadjusted ORs and hazard ratios, 95% CIs, and corresponding P values are shown. To analyze and include the majority of the cohort, some clinical factors were removed on multivariable modeling. However, the significance of the predictor remains in the table of univariate associations.
Because of the long duration of data acquisition, we compared outcomes of early (before January 1996) to more recent subjects with no difference demonstrated regarding clinical events: so, all subjects were included in the final analysis. All statistical analyses were performed using SAS version 9.1.3 (SAS Institute Inc., Cary, NC). The protocol was approved by the institution health research and ethics board.
